SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 63 filers reported holding SILVERBACK THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $91 | -66.0% | 24,072 | -39.8% | 0.00% | -100.0% |
| Q2 2023 | $268 | -18.0% | 39,969 | -20.4% | 0.00% | 0.0% |
| Q1 2023 | $327 | -28.6% | 50,243 | -6.5% | 0.00% | -50.0% |
| Q4 2022 | $458 | -99.9% | 53,714 | -34.5% | 0.00% | 0.0% |
| Q3 2022 | $433,000 | +14.2% | 82,033 | -7.3% | 0.00% | 0.0% |
| Q2 2022 | $379,000 | +27.6% | 88,458 | +4.6% | 0.00% | +100.0% |
| Q1 2022 | $297,000 | -47.3% | 84,566 | -0.2% | 0.00% | -50.0% |
| Q4 2021 | $564,000 | +263.9% | 84,731 | +445.7% | 0.00% | +100.0% |
| Q3 2021 | $155,000 | -68.9% | 15,528 | -3.6% | 0.00% | -50.0% |
| Q2 2021 | $498,000 | -28.0% | 16,108 | +1.6% | 0.00% | -33.3% |
| Q1 2021 | $692,000 | +36.2% | 15,860 | +44.7% | 0.00% | +50.0% |
| Q4 2020 | $508,000 | – | 10,957 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 4,012,903 | $26,123,999 | 9.73% |
| Nextech Invest Ltd. | 1,910,029 | $12,434,289 | 5.19% |
| K2 PRINCIPAL FUND, L.P. | 2,686,490 | $17,489,051 | 2.41% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11,077,927 | $72,117,305 | 1.61% |
| Orbimed Advisors | 8,740,887 | $56,903,174 | 1.12% |
| SECTORAL ASSET MANAGEMENT INC | 793,587 | $5,166,251 | 0.99% |
| Tejara Capital Ltd | 207,555 | $1,351,183 | 0.69% |
| Rubric Capital Management LP | 3,480,712 | $22,659,435 | 0.59% |
| Resolute Capital Asset Partners LLC | 120,000 | $781 | 0.57% |
| RA Capital Management | 3,009,678 | $19,593,004 | 0.44% |